Cordula Stover
library.mans.edu.eg
محمد يوسف ابراهيم محمد - Mohamed Yousef Ibrahim Mohamed · Mohammed Ali, Bernd Echtenacher, Cordula Stover, Daniela Maennel, Wilhelm Schwaeble
3762.pdfThe American Association of Immunologists
journals.aai.org
von B Echtenacher · · Zitiert von: 631 — BERND ECHTENACHER, WERNER FALK,. DANIELA N. MANNEL, AND PETER H. KRAMMER'. From the Institute for Immunology and Genetics, German Cancer Research Center ... von B Echtenacher · · Zitiert von: 631 — BERND ECHTENACHER, WERNER FALK,. DANIELA N. MANNEL, AND PETER H. KRAMMER'. From the Institute for Immunology and Genetics, German Cancer Research Center ...
Hypoferraemia during the early inflammatory response is dependent on...
www.spandidos-publications.com
Authors: Thomas E.O. Schubert, Anja K. Bosserhoff, Carole Peyssonaux, Bernd Echtenacher, Mitchell Knutson, Ferdinand Hofstädter, Daniela ...
VEGF/Flk-1 Interaction, a Requirement for Malignant Ascites...
www.proquest.com
BENJAMIN STOELCKER,1 BERND ECHTENACHER,1 HERBERT A. WEICH,2 HELENA SZTAJER,2,3. DANIEL J. HICKLIN,4 and DANIELA N. MÄNNEL1.
Critical protective role of mast cells in a model of acute ...Nature
www.nature.com
von B Echtenacher · · Zitiert von: — Critical protective role of mast cells in a model of acute septic peritonitis. Bernd Echtenacher, ... Bernd Echtenacher, Daniela N. Männel & ... von B Echtenacher · · Zitiert von: — Critical protective role of mast cells in a model of acute septic peritonitis. Bernd Echtenacher, ... Bernd Echtenacher, Daniela N. Männel & ...
Alle Infos zum Namen "Bernd Echtenacher"
Antimetastatic effects associated with platelet reductionAI Chat for scientific PDFs | SciSpace
typeset.io
Bernhard Nieswandt, Michael Hafner, Bernd Echtenacher, Daniela N. Männel - Show less +1 more. Contribution of platelets to tumour metastasis. [...] 01 Feb ... Bernhard Nieswandt, Michael Hafner, Bernd Echtenacher, Daniela N. Männel - Show less +1 more. Contribution of platelets to tumour metastasis. [...] 01 Feb ...
Datenbank ErgebnisÄrzte gegen Tierversuche
www.aerzte-gegen-tierversuche.de
... Bernd Echtenacher (1) , Daniela N. Männel (1). Institute: (1)*Institut für Pathologie, Uni Regensburg. Zeitschrift: Cancer Research 1999: 59, Land Bernd Echtenacher (1) , Daniela N. Männel (1). Institute: (1)*Institut für Pathologie, Uni Regensburg. Zeitschrift: Cancer Research 1999: 59, Land ...
Involvement of the lectin pathway of complement activation ...Aarhus Universitet
pure.au.dk
Michaela Windbichler, Bernd Echtenacher, Thomas Hehlgans, Jens Christian Jensenius, Wilhelm Schwaeble, Daniela N Männel. Department of Biomedicine - Medical ... Michaela Windbichler, Bernd Echtenacher, Thomas Hehlgans, Jens Christian Jensenius, Wilhelm Schwaeble, Daniela N Männel. Department of Biomedicine - Medical ...
Platelet glycoprotein Ibα supports experimental lung ...AI Chat for scientific PDFs | SciSpace
typeset.io
Bernhard Nieswandt,Michael Hafner,Bernd Echtenacher,Daniela N. Männel +3 more ... Bernhard Nieswandt, Michael Hafner, Bernd Echtenacher, Daniela N. Männel ... Bernhard Nieswandt,Michael Hafner,Bernd Echtenacher,Daniela N. Männel +3 more ... Bernhard Nieswandt, Michael Hafner, Bernd Echtenacher, Daniela N. Männel ...
Requirement of TNF and TNF receptor type 2 for LPS ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von B Echtenacher · · Zitiert von: 30 — Authors. Bernd Echtenacher , Daniela N Männel. Affiliation. 1 Institute for Pathology and Tumor Immunology, University of Regensburg, Regensburg, Germany ... von B Echtenacher · · Zitiert von: 30 — Authors. Bernd Echtenacher , Daniela N Männel. Affiliation. 1 Institute for Pathology and Tumor Immunology, University of Regensburg, Regensburg, Germany ...
Requirement of TNF and TNF receptor type 2 for LPS- ...Sage Journals
journals.sagepub.com
von B Echtenacher · · Zitiert von: 30 — Bernd Echtenacher, Daniela N. Männel. Institute for Pathology and Tumor Immunology, University of Regensburg, Regensburg, Germany. Pretreatment of mice with ... von B Echtenacher · · Zitiert von: 30 — Bernd Echtenacher, Daniela N. Männel. Institute for Pathology and Tumor Immunology, University of Regensburg, Regensburg, Germany. Pretreatment of mice with ...
Requirement of TNF and TNF receptor type 2 for LPS-induced ...Sage Journals
journals.sagepub.com
Bernd Echtenacher and Daniela N. MännelView all authors and affiliations. Volume 8, Issue 5 · https://doi.org Contents. Abstract ... Bernd Echtenacher and Daniela N. MännelView all authors and affiliations. Volume 8, Issue 5 · https://doi.org Contents. Abstract ...
Requirement of endogenous tumor necrosis factor ...Scite.ai
scite.ai
Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. Bernd Echtenacher. ,. Werner Falk. ,. Daniela N ... Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. Bernd Echtenacher. ,. Werner Falk. ,. Daniela N ...
Treatment of experimental sepsis-induced ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von B Echtenacher · · Zitiert von: 46 — Authors. Bernd Echtenacher , Renate Urbaschek, Karin Weigl, Marina A Freudenberg, Daniela N Männel. Affiliation. 1 Institute for Pathology/Tumor Immunology ... von B Echtenacher · · Zitiert von: 46 — Authors. Bernd Echtenacher , Renate Urbaschek, Karin Weigl, Marina A Freudenberg, Daniela N Männel. Affiliation. 1 Institute for Pathology/Tumor Immunology ...
Tumor Necrosis Factor-Dependent Adhesions as a Major ...ASM Journals
journals.asm.org
von B Echtenacher · · Zitiert von: 150 — BERND ECHTENACHER,1 KARIN WEIGL,1 NORBERT LEHN,2. AND DANIELA N. MÄNNEL1*. Department of Pathology, Tumor Immunology,1 and Institute of Microbiology and ... von B Echtenacher · · Zitiert von: 150 — BERND ECHTENACHER,1 KARIN WEIGL,1 NORBERT LEHN,2. AND DANIELA N. MÄNNEL1*. Department of Pathology, Tumor Immunology,1 and Institute of Microbiology and ...
VEGF/Flk-1 Interaction, a Requirement for Malignant ...Mary Ann Liebert, Inc.
www.liebertpub.com
von B Stoelcker · · Zitiert von: 54 — BENJAMIN STOELCKER,1 BERND ECHTENACHER,1 HERBERT A. WEICH,2 HELENA SZTAJER,2,3. DANIEL J. HICKLIN,4 and DANIELA N. MÄNNEL1. ABSTRACT. Vascular endothelial ... von B Stoelcker · · Zitiert von: 54 — BENJAMIN STOELCKER,1 BERND ECHTENACHER,1 HERBERT A. WEICH,2 HELENA SZTAJER,2,3. DANIEL J. HICKLIN,4 and DANIELA N. MÄNNEL1. ABSTRACT. Vascular endothelial ...
[PDF] Requirement of endogenous tumor necrosis factor ...Semantic Scholar
www.semanticscholar.org
}, author={Bernd Echtenacher and Werner Falk and Daniela N M{\"a}nnel and Peter H. Krammer}, journal={Journal of immunology}, year={1990}, volume={ }, author={Bernd Echtenacher and Werner Falk and Daniela N M{\"a}nnel and Peter H. Krammer}, journal={Journal of immunology}, year={1990}, volume={
Critical protective role of mast cells in a model of acute septic...
www.proquest.com
Bernd Echtenacher, Daniela N. Mannel & Lothar Hultner*. Institut for Pathologie/Tumorimmunologie, Universitat Regensburg, Franz-Josef-Strauss-Allee, ...
WikiGenes - Cfp - complement factor properdin
www.wikigenes.org
... Laval, S.H. et al. Wilhelm J. Schwaeble, Aline Dupont, Cordula M. Stover, Sue E. Figgitt, Jeni C. Luckett, Jane Brown, Bernd Echtenacher, Daniela N. Männel, ...
sortiert nach Relevanz / Datum